LONG-TERM WARFARIN USE MAY INCREASE RISK OF FRACTURES IN MEN

JUNE 01, 2006
Anna D. Garrett, PharmD, BCPS, CPP

A study of Medicare beneficiaries with atrial fibrillation who were hospitalized between March 1998 and April 1999 throughout the country found that men who were on longterm (defined as >1 yr) warfarin therapy were 63% more likely to suffer an osteoporosis-related fracture of the hip, spine, or wrist.Women on long-term therapy and patients who took the drug for <1 year had no significant increase in risk.

Vitamin K is involved in the activation of bone proteins. Warfarin's inhibition of this activation process because of vitamin K antagonism may explain why patients on long-term therapy face an increased risk of osteoporosis. The study also found that patients who were on beta-blockers or who had high dietary intake of vitamin K and folate had a decreased risk of fractures.

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.




SHARE THIS SHARE THIS
0
 

Conference Coverage

Check back here regularly for live conference coverage from the American Academy of Pain Medicine and the upcoming American Pharmacists Association Meeting and Expo. 


 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.